SEATTLE, Jan. 28 /PRNewswire-FirstCall/ -- Omeros Corporation (NASDAQ: OMER) today announced that the National Institute on Drug Abuse (NIDA) is providing support for the Company's Addiction...
SEATTLE, Nov. 19 /PRNewswire-FirstCall/ -- Omeros Corporation (NASDAQ: OMER) today announced unaudited financial results for the third quarter ended September 30, 2009. For the three months...
SEATTLE, WA, Nov. 13 /PRNewswire-FirstCall/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on...
SEATTLE, Wash., Oct. 7 /PRNewswire-FirstCall/ -- Omeros Corporation today announced the pricing of its initial public offering of 6.82 million shares of its common stock at a price of $10.00 per...
SEATTLE, Sept. 18 /PRNewswire-FirstCall/ -- Omeros Corporation today announced the launch of its initial public offering of 6.82 million shares of its common stock. Omeros is a clinical-stage...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.22 | 5.52763819095 | 3.98 | 4.48 | 3.93 | 6228 | 4.24019269 | DE |
4 | -0.2 | -4.54545454545 | 4.4 | 4.6 | 3.75 | 7909 | 4.13769315 | DE |
12 | 0.3 | 7.69230769231 | 3.9 | 4.6 | 3.75 | 8541 | 4.23785487 | DE |
26 | 0.53 | 14.4414168937 | 3.67 | 4.6 | 3.61 | 9085 | 4.02405876 | DE |
52 | 1.55 | 58.4905660377 | 2.65 | 4.6 | 2.6 | 11949 | 3.59036234 | DE |
156 | 0.25 | 6.32911392405 | 3.95 | 4.6 | 2.15 | 10829 | 3.26864947 | DE |
260 | 0.788 | 23.0949589683 | 3.412 | 4.6 | 2.15 | 14670 | 3.50637171 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.